Azaz et al, Chem. Abst. 96:74626N (1982). |
Hirai, International Journal of Pharmaceutical, 174-184, 1981. |
Muranishi, "Absorption Barriers and Absorption Promoters in the Intestine", Topics in Pharmaceuticals Sciences (1987), pp. 445-455. |
Jerusalem University, IL 54041, "Pharmaceutical composition for enteral or vaginal application" (1981). |
Morimoto, et al., "Effect of non-ionic surfactants in a polyacrylic acid gel base on the rectal absorption of �Asu 1,7!-eel calcitonin in rats", J. Pharm. Pharmacol., vol. 37 (1985), pp. 759-760. |
Okada, "Vaginal Administration of a Potent Luteinizing Hormone-Releasing Hormone Analog (Leuprolide)", J. Takeda Res. Lab., 42 (1/2) (1983), pp. 150-208. |
Touitou, et al., "New hydrophilic vehicle enabling rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin", J. Pharm. Pharmac., vol. 30 (1978), pp. 662-663. |
Saito, et al., "Stimulation of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone by �D-LEU.sup.6,DES-GLY.sup.10 -NH.sub.2 !-LH-Releasing Hormone Ethylamide After Subcutaneous, Intravaginal, and Intrarectal Administration To Women", Fertility and Sterility, vol. 28, No. 3 (1977), pp. 240-245. |
Okada, et al., "Vaginal Absdorption of a Potent Luteinizing Hormone-Releasing Hormone Analogoue (Leuprolide) in Rats II: Mechanism of Absorption Enhancement with Organic Acids", Journal of Pharmaceutical Sciences, vol. 72, No. 1 (1983), PP. 75-78. |
Okada, Journal of Pharmaceutical Sciences, 71, No. 12, 1366-1371 (1982). |